25984 Gastrointestinal adverse events related to study drug and leading to discontinuation through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials
Autor: | Amy Baum-Jones, Melinda Gooderham, Alan M. Mendelsohn, Boni E. Elewski, Stephen J. Rozzo, Jennifer Conner |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Journal of the American Academy of Dermatology. 85:AB78 |
ISSN: | 0190-9622 |
Databáze: | OpenAIRE |
Externí odkaz: |